Admission & Hospitalization Reduction
NICaS can help in reducing readmission & hospitalization rates for heart failure patients. Our technology can assist in the assessment and management of CHF patients in various settings.
Reducing Readmission & Hospitalization Rates for Heart Failure Patients
How NICaS Helps Reduce Hospitalization and Readmission Rates:
Utilizing NICaS technology, provided by NI-Medical, can effectively reduce hospitalization and readmission rates for heart failure, including reversions from outpatient settings back to the hospital.
NICaS is accurate, and more importantly, it is consistent. This allows assessment of a patient’s clinical response to medication adjustments over time. NICaS enables medication titration not previously seen in these CHF patients.
NICaS takes the guesswork out of managing difficult patients with heart failure. It facilitates expeditious optimization of these patients.
NICaS helps to identify patients with impending heart failure before they reach the stage of decompensation, allowing the time to make the necessary adjustments that prevent deterioration.
Using NICaS for the management of HF patients reduces Hospital Readmission Rate by over 90%.
Heart Failure Hospitalizations In Numbers
CHF is the chief diagnosis in 875,000 hospitalizations annually, and the most common diagnosis in hospital patients aged 65 years and older.
Heart failure is responsible for 11 million physician visits each year, and leads to more hospitalizations than all forms of cancer combined.
The majority of hospital admissions for heart failure are, in fact, readmissions.
Approximately 24% of the people discharged from the hospital with heart failure will be readmitted within 30 days. More than half of them will be readmitted within 6 months.
Heart failure is the number one discharge diagnosis seen by Medicare. The direct and indirect costs of heart failure add up to about $40 billion annually.
Related Clinical Markets
Related Clinical Studies
Non-Invasive Hemodynamic Whole-Body Bioimpedance Indices for the Early Detection of Cancer Treatment-Related Cardiotoxicity: A Retrospective Observational Study
Authors: Nili Schamroth Pravda, Shaul Lev , Osnat Itzhaki Ben Zadok, Ran Kornowski, Zaza Iakobishvili Conclusion: GGI, a parameter measured by WBI, can reliably correlate
Authors: Gad Cotter , Yaron Moshkovitz, Edo Kaluski, Amram J Cohen, Hilton Miller, Daniel Goor, Zvi Vered The results of the study indicate that the
The Clinical Research of NICaS for Monitoring Changes of Cardiac Function in Patients with Sepsis (part 2)
Authors: Zhu Yan Second Military Medical University CONCLUSION: (1) In patients with sepsis thrombocytopenia, a high SOFA score indicates that the patient is in critical
The Clinical Research of NICaS for Monitoring Changes of Cardiac Function in Patients with Sepsis (two part study – part 1)
Authors: Zhu Yan Second Military Medical University CONCLUSION: NICaS can measure the cardiac output and stroke volume in sepsis patients as accurate as ultrasonic Cardiogram,
Authors: Guo Longzhe, Ning Wenlong, Liu Fei, Wang Xueyan, Xin Chuanyou, Zhong Lijuan, Zhou Guangjun, Bao Haibo, Du Aijun. Conclusion: NICAS can more accurately assess
Non-Invasive hemodynamic monitoring in TAVI-patients reveals more pronounced early in-hospital circulatory recovery for low-gradient aortic stenosis
Authors: Birgit Markus, Holger Ahrens, Bernard Schieffer and more. Conclusion: NICaS monitoring represents an accurate non-invasive bedside tool to discriminate adaptive circulatory changes in subgroups